IUBio GIL .. BIOSCI/Bionet News .. Biosequences .. Software .. FTP

Roche vs Promega Latest

Kevin O'Donnell odonnell at sasa.gov.uk
Thu Jun 1 08:15:57 EST 1995

Scientists are getting caught in the cross-fire in the legal battle between 
Roche and promega over the taq polymerase (used in PCR)patent. 
Briefly, Promega are trying to get the patent overturned in the US 
because it is 'prior art'  i.e. they maintain that taq had been described 
previous to the patent being granted to Cetus (who sold it to Roche).

The latest thing is that Roche have compiled a list of over 200 US 
scientists in universities and laboratories who they say have acted illegally. 
The list seems to consist of people who have published papers in which 
the source of their taq was Promega.   The full list is available on 
Promega's WWW page (http://www.promega.com) as are more details 
about the litigation.

The European taq patent has been withdrawn, pending further 
investigation, partly as a result of the Promega action.

I should say here that this info is distilled from the Promega press release 
which may not be the most objective source. 

I would also like to declare an interest: I am sick and tired of being ripped 
off by taq prices several times the real cost.
Kevin O'Donnell
Scottish Agricultural Science Agency    

More information about the Diagnost mailing list

Send comments to us at archive@iubioarchive.bio.net